Celltrion showcases positive oneyear results for subcutaneous formulation of infliximab in patients with active Crohns disease and ulcerative colitis

Results presented at The European Crohn&8217;s and Colitis Organisation ECCO 2020 annual congress in Vienna Austria demonstrated that the SC formulation of CTP13 was comparable to the IV The post Celltrion showcases positive oneyear results for subcuta...